Aptahem hosts “Way Forward for Apta-1” webinar, replay now available

Bitget2026/09/30 14:14

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Aptahem hosted a webinar on Sept. 28, 2026 outlining its clinical development strategy for lead candidate Apta-1.
CEO Mikael Lindstam also discussed ongoing partnership efforts alongside the company’s ongoing rights issue of units.
Apta-1 remains in early-stage clinical development, targeting acute, life-threatening conditions involving coagulation, inflammation, and tissue damage.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptahem AB published the original content used to generate this news brief via Cision (Ref. ID: 202609301013BITN____UKPR__SV_20260930-BIT-7509-0) on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Aptahem hosts “Way Forward for Apta-1” webinar, replay now available

You may also like

Crypto prices